{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:32:55Z","timestamp":1791999175151,"version":"4.4.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.jaci.2013.10.037","type":"journal-article","created":{"date-parts":[[2013,12,10]],"date-time":"2013-12-10T00:46:22Z","timestamp":1386636382000},"page":"439-447","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Transcutaneous yellow fever vaccination of subjects with or without atopic dermatitis"],"prefix":"10.1016","volume":"133","author":[{"given":"Mark K.","family":"Slifka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald Y.M.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Hammarlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Peter","family":"Rau\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric L.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Tofte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahana","family":"Baig-Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Lynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"Woolson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tissa","family":"Hata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Milgrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Hanifin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2013.10.037_bib1","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1056\/NEJMra074081","article-title":"Atopic dermatitis","volume":"358","author":"Bieber","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2013.10.037_bib2","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1067\/mjd.2002.120528","article-title":"Cost of atopic dermatitis and eczema in the United States","volume":"46","author":"Ellis","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2013.10.037_bib3","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jaci.2009.05.020","article-title":"Phenotype of atopic dermatitis subjects with a history of eczema herpeticum","volume":"124","author":"Beck","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2013.10.037_bib4","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/jama.1970.03170160031005","article-title":"Deaths attributable to smallpox vaccination, 1959 to 1966, and 1968","volume":"212","author":"Lane","year":"1970","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2013.10.037_bib5","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1093\/cid\/cir952","article-title":"Eczema vaccinatum","volume":"54","author":"Reed","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaci.2013.10.037_bib6","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1001\/jama.289.24.3278","article-title":"US military smallpox vaccination program experience","volume":"289","author":"Grabenstein","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2013.10.037_bib7","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1080\/00034983.1957.11685814","article-title":"Mass vaccination against yellow fever\u00a0by\u00a0scarification with 17D strain vaccine","volume":"51","author":"Cannon","year":"1957","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.jaci.2013.10.037_bib8","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/0035-9203(57)90125-6","article-title":"Yellow fever vaccination by scarification with the 17D strain: an\u00a0appreciation of the present position","volume":"51","author":"Meers","year":"1957","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.jaci.2013.10.037_bib9","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0035-9203(60)90099-7","article-title":"Further observations on 17D-yellow fever vaccination by scarification, with and without simultaneous smallpox vaccination","volume":"54","author":"Meers","year":"1960","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.jaci.2013.10.037_bib10","series-title":"Vaccines","first-page":"959","article-title":"Yellow fever vaccine","author":"Monath","year":"2008"},{"key":"10.1016\/j.jaci.2013.10.037_bib11","doi-asserted-by":"crossref","first-page":"533","DOI":"10.4269\/ajtmh.2002.66.533","article-title":"Comparative safety and immunogenicity of two yellow fever 17D vaccines (ARILVAX and YF-VAX) in a phase III multicenter, double-blind clinical trial","volume":"66","author":"Monath","year":"2002","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jaci.2013.10.037_bib12","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1056\/NEJMoa1009303","article-title":"An\u00a0inactivated cell-culture vaccine against yellow fever","volume":"364","author":"Monath","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2013.10.037_bib13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/(SICI)1096-9071(199810)56:2<159::AID-JMV10>3.0.CO;2-B","article-title":"Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection","volume":"56","author":"Reinhardt","year":"1998","journal-title":"J Med Virol"},{"key":"10.1016\/j.jaci.2013.10.037_bib14","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/nm917","article-title":"Duration of antiviral immunity after smallpox vaccination","volume":"9","author":"Hammarlund","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2013.10.037_bib15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1467-9469.2005.00414.x","article-title":"Generalized log-rank tests for interval-censored failure time data","volume":"32","author":"Sun","year":"2005","journal-title":"Scand J Stat"},{"key":"10.1016\/j.jaci.2013.10.037_bib16","doi-asserted-by":"crossref","first-page":"316","DOI":"10.4161\/hv.4.4.5751","article-title":"Protective immunity following vaccination: How is it defined?","volume":"4","author":"Amanna","year":"2008","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.jaci.2013.10.037_bib17","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.immuni.2008.02.020","article-title":"Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines","volume":"28","author":"Miller","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2013.10.037_bib18","doi-asserted-by":"crossref","first-page":"7919","DOI":"10.4049\/jimmunol.0803903","article-title":"The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response","volume":"183","author":"Akondy","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2013.10.037_bib19","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1046\/j.0905-6157.2003.00106.x","article-title":"Does the severity of atopic dermatitis correlate with serum IgE levels?","volume":"15","author":"Laske","year":"2004","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaci.2013.10.037_bib20","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4161\/hv.1.3.1797","article-title":"Cutaneous delivery of a live, attenuated chimeric flavivirus vaccine against Japanese encephalitis (ChimeriVax)-JE) in non-human primates","volume":"1","author":"Dean","year":"2005","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.jaci.2013.10.037_bib21","doi-asserted-by":"crossref","first-page":"e1993","DOI":"10.1371\/journal.pone.0001993","article-title":"Intradermally\u00a0administered yellow fever vaccine at reduced dose induces a protective immune response: a randomized controlled non-inferiority trial","volume":"3","author":"Roukens","year":"2008","journal-title":"PLoS\u00a0One"},{"key":"10.1016\/j.jaci.2013.10.037_bib22","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1016\/j.vaccine.2008.09.009","article-title":"Adverse event reports following yellow fever vaccination","volume":"26","author":"Lindsey","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.jaci.2013.10.037_bib23","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1016\/j.vaccine.2006.12.015","article-title":"17D yellow fever vaccines: new insights. A\u00a0report of a workshop held during the World Congress on medicine and health in the tropics, Marseille, France, Monday 12 September 2005","volume":"25","author":"Barrett","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.jaci.2013.10.037_bib24","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2471\/BLT.10.079426","article-title":"Intradermal delivery of vaccines: potential benefits and current challenges","volume":"89","author":"Hickling","year":"2011","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.jaci.2013.10.037_bib25","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/irv.12000","article-title":"A meta-analysis of intradermal versus intramuscular influenza vaccines: immunogenicity and adverse events","volume":"7","author":"Marra","year":"2013","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.jaci.2013.10.037_bib26","doi-asserted-by":"crossref","first-page":"357","DOI":"10.4155\/tde.12.13","article-title":"Microneedle delivery: clinical studies and emerging medical applications","volume":"3","author":"Pettis","year":"2012","journal-title":"Ther Deliv"},{"key":"10.1016\/j.jaci.2013.10.037_bib27","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1517\/17425247.2012.676038","article-title":"Microneedle-mediated vaccine delivery: harnessing cutaneous immunobiology to improve efficacy","volume":"9","author":"Al-Zahrani","year":"2012","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.jaci.2013.10.037_bib28","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1001\/jama.1985.03360220069031","article-title":"Clinical evaluation of low-dose intradermally administered hepatitis B virus vaccine. A\u00a0cost reduction strategy","volume":"254","author":"Redfield","year":"1985","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2013.10.037_bib29","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa043540","article-title":"Dose sparing with\u00a0intradermal injection of influenza vaccine","volume":"351","author":"Kenney","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2013.10.037_bib30","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1056\/NEJMoa043555","article-title":"Serum antibody responses after intradermal vaccination against influenza","volume":"351","author":"Belshe","year":"2004","journal-title":"N\u00a0Engl J Med"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674913016989?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674913016989?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:48:30Z","timestamp":1758790110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674913016989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0091674913016989"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2013.10.037","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transcutaneous yellow fever vaccination of subjects with or without atopic dermatitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2013.10.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}